Review article · 2026 · Open access
A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE CLINICAL EFFICACY AND SAFETY OF BACTERIOPHAGES IN BACTERIAL INFECTIONS
Eurasian journal of applied biotechnology, 430–450 · Published 20 October 2026 · DOI 10.11134/btp.3.2026.45
In brief
“A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE CLINICAL EFFICACY AND SAFETY OF BACTERIOPHAGES IN BACTERIAL INFECTIONS” is a 2026 review article by Nurgul S. Sikhayeva and 6 co-authors, published in Eurasian journal of applied biotechnology. OpenAlex counts 0 citations as of 15 November 2026. It is open access: the full text is free to read at Eurasian journal of applied biotechnology.
- Citations
- 0
- References
- 28
- Authors
- 7
Abstract
The growing number of infections caused by multidrug-resistant bacteria (MDR) makes the development of alternative therapeutic strategies a priority of modern medicine. Bacteriophage therapy is considered as a promising method for the treatment of resistant infections; however, a systematic synthesis of clinical data remains an urgent task. The purpose of this review is to systematically summarize clinical data on bacteriophage therapy in humans and estimate the proportion of patients with clinical improvement. A systematic search was performed in the PubMed/MEDLINE, Embase, and Cochrane CENTRAL databases (January 2000 - February 2026). Randomized controlled trials (RCTs), cohort studies, case series, and compassionate use studies with ≥3 participants were included. Primary outcome – percentage of patients with clinical improvement. The meta-analysis was performed using a random effects model (DerSimonian–Laird method, logit transformation, Hartung–Knapp correction). The risk of systematic error was assessed using the RoB 2 (for RCTs) and ROBINS-I (for non-randomized studies) instruments. The review was carried out in accordance with the PRISMA 2020 guidelines. As a result, the final analysis included 17 studies (683 patients; 9 RCTs, 1 randomized uncontrolled study, and 7 nonrandomized studies) from more than 10 countries. The most studied pathogens were Pseudomonas aeruginosa, Staphylococcus aureus and Escherichia coli. The pooled proportion of patients with clinical improvement was 57.2% (95% CI: 35.9–76.1%; k=8, N=393), with high heterogeneity (I²=88.2%; prediction interval: 10.7–93.7%). In the leave-one-out analysis, the pooled proportion ranged from 52.6% to 63.1%. The reviewed publications did not report any serious adverse events with a confirmed relationship to phage administration. Four RCTs had a low risk of bias. In conclusion, published studies showed acceptable tolerability of bacteriophage therapy, with no reports of phage-related serious adverse events, and evidence suggestive of clinical benefit, particularly as an adjunct to antibiotic therapy for MDR infections. High heterogeneity, the predominance of uncontrolled study designs, and the noncomparative nature of the pooled estimate preclude conclusions about the efficacy of phage therapy relative to standard treatment. Large multicenter RCTs with standardized outcomes and systematic recording of adverse events are needed, along with standardization of the pharmaceutical quality of phage preparations.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Sikhayeva, N. S., Dyussenbekova, A., Bekeshova, K., Esenbekova, N., Kanalyn, Z., Rsaliyev, A., & Abduraimov, Y. O. (2026). A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE CLINICAL EFFICACY AND SAFETY OF BACTERIOPHAGES IN BACTERIAL INFECTIONS. Eurasian journal of applied biotechnology, 430–450. https://doi.org/10.11134/btp.3.2026.45
MLA 9
Sikhayeva, Nurgul S., et al. “A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE CLINICAL EFFICACY AND SAFETY OF BACTERIOPHAGES IN BACTERIAL INFECTIONS.” Eurasian journal of applied biotechnology, no. 3, 2026, pp. 430–450. https://doi.org/10.11134/btp.3.2026.45.
Chicago
Sikhayeva, Nurgul S., A.S. Dyussenbekova, K.B. Bekeshova, N.A. Esenbekova, Zh.D. Kanalyn, Aralbek Rsaliyev, and Yergali O. Abduraimov. 2026. “A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE CLINICAL EFFICACY AND SAFETY OF BACTERIOPHAGES IN BACTERIAL INFECTIONS.” Eurasian journal of applied biotechnology (3): 430–450. https://doi.org/10.11134/btp.3.2026.45.
Harvard
Sikhayeva, N. S. et al. (2026) ‘A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE CLINICAL EFFICACY AND SAFETY OF BACTERIOPHAGES IN BACTERIAL INFECTIONS’, Eurasian journal of applied biotechnology, pp. 430–450. doi:10.11134/btp.3.2026.45.
IEEE
N. S. Sikhayeva et al., “A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE CLINICAL EFFICACY AND SAFETY OF BACTERIOPHAGES IN BACTERIAL INFECTIONS,” Eurasian journal of applied biotechnology, no. 3, pp. 430–450, 2026, doi: 10.11134/btp.3.2026.45.
BibTeX
@article{sikhayeva2026systematic,
title = {{A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE CLINICAL EFFICACY AND SAFETY OF BACTERIOPHAGES IN BACTERIAL INFECTIONS}},
author = {Sikhayeva, Nurgul S. and Dyussenbekova, A.S. and Bekeshova, K.B. and Esenbekova, N.A. and Kanalyn, Zh.D. and Rsaliyev, Aralbek and Abduraimov, Yergali O.},
journal = {Eurasian journal of applied biotechnology},
year = {2026},
number = {3},
pages = {430--450},
doi = {10.11134/btp.3.2026.45},
url = {https://doi.org/10.11134/btp.3.2026.45}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Immunology and Microbiology › Virology › Bacteriophages and microbial interactions
- phage therapy
- multidrug-resistant bacteria
- bacterial infection
- clinical efficacy
- treatment safety
- adverse events
- Pseudomonas aeruginosa
- Staphylococcus aureus
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Sikhayeva, N. S., Dyussenbekova, A., Bekeshova, K., Esenbekova, N., Kanalyn, Z., Rsaliyev, A., & Abduraimov, Y. O. (2026). A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE CLINICAL EFFICACY AND SAFETY OF BACTERIOPHAGES IN BACTERIAL INFECTIONS. Eurasian journal of applied biotechnology, 430–450. https://doi.org/10.11134/btp.3.2026.45
How many times has this paper been cited?
0 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access: read the free full text at Eurasian journal of applied biotechnology.
Who wrote this paper?
Nurgul S. Sikhayeva, A.S. Dyussenbekova, K.B. Bekeshova, N.A. Esenbekova, Zh.D. Kanalyn, Aralbek Rsaliyev, Yergali O. Abduraimov.
What is the DOI of this paper?
10.11134/btp.3.2026.45. The permanent link is https://doi.org/10.11134/btp.3.2026.45.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.